Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Daily PPI Use on Renal Function
NCT03910647Phase 2Unknown
- Sponsor
- Assiut University
- Start
- Dec 2019
- Primary completion
- Dec 2020
- Modality
- Small Molecules
01
Overview
Phase 2, open-label trial of pantoprazole in Peptic ulcer disease (PUD) and gastroesophageal reflux disease (GERD) (2 arms), sponsored by Assiut University. Primary endpoint: Kidney function at 1 month. Status: unknown.
02
Drugs
pantoprazole
03
Conditions
Peptic ulcer disease (PUD)gastroesophageal reflux disease (GERD)
Beyond the preview
Go deeper on NCT03910647.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03910647.